Skip to content

Ultrasound Guided Ganglion Impar Block

Ultrasound Guided Ganglion Impar Block

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06886568
Enrollment
30
Registered
2025-03-20
Start date
2025-04-01
Completion date
2025-07-15
Last updated
2025-03-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Coccydynia

Keywords

Coccydynia, pain, ultrasound guided injection, ganglion impar

Brief summary

The aim of this study is to evaluate feasibility, reliability and short term effectiveness of ganglion impar block with ultrasound in patients with chronic coccygodinia.

Detailed description

Ganglion impar blocks have long been used for coccydynia, either with a landmark-based technique or fluoroscopic guidance. With the growing use of ultrasound, ultrasound-guided ganglion impar block has become a viable alternative. Despite its frequent use in clinical practice, ultrasound has limitations in visualizing structures behind the bone, while fluoroscopy remains the gold standard. Further research is needed to evaluate its feasibility, safety, and efficacy. This study primarily aims to assess the feasibility and safety of ultrasound-guided ganglion impar block in coccydynia. Additionally, it will examine its short-term (1-month) efficacy.

Interventions

PROCEDUREUltrasound-guided ganglion impar block

The procedure will be performed under sterile conditions and continuous monitoring. Using an ultrasound device with a 10-12 MHz linear probe, a 22G spinal needle will be advanced into the sacrococcygeal joint space using the out-of-plane technique. After confirming loss of resistance with a syringe containing normal saline as the needle exits the capsule anterior to the joint, approximately 1 mL of contrast medium will be injected. Anteroposterior (AP) and lateral fluoroscopic images will be obtained to verify the spread of the contrast agent. Once adequate contrast distribution is confirmed anterior to the coccyx on the lateral view, a mixture of dexamethasone and bupivacaine will be injected to complete the block. Procedures that cannot be completed or successfully visualized under ultrasound guidance will be finalized under fluoroscopic guidance.

Sponsors

Başakşehir Çam & Sakura City Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Age between 18-65 years. * Coccydynia persisting for at least three months. * Being scheduled for a ganglion impar block in the pain medicine outpatient clinic. * Having inadequate response to medical and conservative treatments. * Aggreeing to undergo the interventional procedure and participate in the study.

Exclusion criteria

* Local infection at the injection site. * Bleeding disorders or diseases and drugs that may cause bleeding diatesis (e.g. renal failure, liver failure, anticoagulant treatments) * History of allergic reaction to the medications to be used. * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Injection accuracyPost-procedure 1st hourIn all patients, the sacrococcygeal or transcoccygeal space will be identified under ultrasound guidance. A 22-gauge spinal needle will be advanced into the joint space under ultrasound visualization. Using a saline-filled syringe, the loss-of-resistance technique will be employed to confirm passage through the joint space and entry into the retroperitoneal space. Subsequently, a lateral fluoroscopic image will be obtained, and contrast medium will be injected to verify needle placement. If appropriate contrast dispersion is observed along the midline, the procedure will be considered successful, and the medication will be administered. If contrast distribution is inadequate (e.g. vascular spread, non-midline spread), the procedure will be discontinued under ultrasound guidance and resumed under fluoroscopic guidance.

Secondary

MeasureTime frameDescription
Visual Analogue ScaleBaseline, 1st hour, 1st week, 1st monthPain intensity will be assessed using the Visual Analogue Scale (VAS), a 10-point scale where 1 indicates no pain and 10 represents the worst pain.
Pain-free sitting durationBaseline, 1st hour, 1st week, 1st monthPain-free sitting duration (minutes) will be recorded.
The number of attemptsPost-procedure 1st hourThe number of attempts will be recorded.
Technical difficulty of injectionPost-procedure 1st hourThe technical difficulty of the injection will be assessed using a 10-item scale, where 1 indicates no difficulty and 10 represents the highest level of difficulty
ComplicationsBaseline, 1st hour, 1st week, 1st monthAll complications following the injection will be recorded, including infections, bleeding, hematoma, allergic reactions, steroid-related complications, transient hypoesthesia, and weakness, among others.

Countries

Turkey (Türkiye)

Contacts

Primary ContactTuba Tanyel Saraçoğlu, MD
tuba.saracoglu1@saglik.gov.tr00902129096000
Backup ContactDuygu Karali-Bingul, MD
d_karali@yahoo.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026